tiprankstipranks
Advertisement
Advertisement
Vivani Medical: Buy Rating Reaffirmed as Novo Nordisk Evaluation and Cortigent–ClearOne Merger Support $3.50 Price Target
PremiumRatingsVivani Medical: Buy Rating Reaffirmed as Novo Nordisk Evaluation and Cortigent–ClearOne Merger Support $3.50 Price Target
1M ago
Vivani Advances GLP-1 Implant Program With Novo Nordisk
Premium
Company Announcements
Vivani Advances GLP-1 Implant Program With Novo Nordisk
2M ago
Vivani Medical enters pact with Novo Nordisk to evaluate NPM-139
Premium
The Fly
Vivani Medical enters pact with Novo Nordisk to evaluate NPM-139
2M ago
Vivani receives approval from Bellberry to initiate SLIM-1 trial in Australia
PremiumThe FlyVivani receives approval from Bellberry to initiate SLIM-1 trial in Australia
2M ago
Vivani Medical initiated with a Buy at Lake Street
Premium
The Fly
Vivani Medical initiated with a Buy at Lake Street
2M ago
Vivani Medical director buys $2.0M in common stock
Premium
The Fly
Vivani Medical director buys $2.0M in common stock
2M ago
Vivani: Solid Funding Runway and Strategic Catalysts Underpin Buy Rating
PremiumRatingsVivani: Solid Funding Runway and Strategic Catalysts Underpin Buy Rating
5M ago
Vivani Medical, Inc. (VANI) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Vivani Medical, Inc. (VANI) Q4 Earnings Cheat Sheet
5M ago
Vivani’s Cortigent presents 6-year results for Orion system at NANS 2026
Premium
The Fly
Vivani’s Cortigent presents 6-year results for Orion system at NANS 2026
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100